Regional colorectal cancer screening program using colonoscopy on an island: a prospective Nii-jima study

被引:7
|
作者
Hotta, Kinichi [1 ]
Matsuda, Takahisa [2 ]
Kakugawa, Yasuo [2 ]
Ikematsu, Hiroaki [3 ]
Kobayashi, Nozomu [4 ]
Kushima, Ryoji [5 ]
Hozawa, Atsushi [6 ]
Nakajima, Takeshi [3 ]
Sakamoto, Taku [3 ]
Mori, Mika [3 ]
Fujii, Takahiro [7 ]
Saito, Yutaka [3 ]
机构
[1] Shizuoka Canc Ctr, Div Endoscopy, Shizuoka, Japan
[2] Natl Canc Ctr, Cancer Screening Ctr, Endoscopy Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
[3] Natl Canc Ctr Hosp East, Endoscopy Div, Kashiwa, Chiba, Japan
[4] Tochigi Canc Ctr, Dept Diagnost Imaging, Utsunomiya, Tochigi, Japan
[5] Natl Canc Ctr, Pathol Div, Tokyo, Japan
[6] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi, Japan
[7] TF Clin, Tokyo, Japan
关键词
colorectal cancer; screening; colonoscopy; colorectal adenoma; FECAL-OCCULT-BLOOD; TRIAL; MORTALITY; KEELUNG; MODEL;
D O I
10.1093/jjco/hyw155
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Colorectal cancer screening program using fecal immunochemical test had been conducted on an isolated island named Nii-jima. However, the participation rate of the program had been approximately 12%, which was lower than average level of Japan. This study aimed to evaluate the participation rate, safety and efficacy of a colorectal cancer screening program using colonoscopy on the island. Methods: Educational campaigns were actively conducted every month using information bulletins and special propaganda pamphlets. The primary recommended modality was colonoscopy, followed by fecal immunochemical test. The participants of this program were 1671 individuals aged 40-79 years (men, 819; women, 852). Results: A total of 789 (47.2%) individuals provided consent for this screening program, and 89.2% (704/789) of participants chose colonoscopy as the primary screening procedure. The completion rate of total colonoscopy was 99.7%, and there was no complication during this program. Detection rates of invasive cancer, intramucosal cancer, advanced neoplasia and any adenoma were 0.9% (n = 6), 2.4% (n = 17), 11.8% (n = 83) and 50.0% (n = 352), respectively. The adenoma detection rate and incidence of advanced neoplasia were significantly higher in men than in women in all age groups. Conclusions: The colorectal cancer screening program using colonoscopy that was conducted on an island achieved considerably higher participation rate than the conventional screening program using fecal immunochemical test. Completion rate and safety of screening colonoscopy were excellent during this program.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 50 条
  • [1] Regional colorectal cancer screening program using colonoscopy on an island: a prospective Niijima study
    Hotta, Kinichi
    Mastuda, Takahisa
    Kakugawa, Yasuo
    Ikematsu, Hiroaki
    Kobayashi, Nozomu
    Kushima, Ryoji
    Murakami, Yoshitaka
    Ishikawa, Hideki
    Nakajima, Takeshi
    Otake, Yosuke
    Sakamoto, Taku
    Matsumoto, Minori
    Abe, Seiichiro
    Mori, Mika
    Fujii, Takahiro
    Saito, Yutaka
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 56 - 56
  • [2] Outpatient Colonoscopy Complications in the CDC's Colorectal Cancer Screening Demonstration Program A Prospective Analysis
    Castro, Georgina
    Azrak, M. Fuad
    Seeff, Laura C.
    Royalty, Janet
    CANCER, 2013, 119 : 2849 - 2854
  • [3] Screening colonoscopy and colorectal cancer: asinglecenter long term study
    Schoenfeld, Juergen V.
    Mueller-Steden, B.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (04): : 312 - 315
  • [4] Colorectal cancer surveillance by colonoscopy in a prospective, population-based long-term Swiss screening study - outcomes, adherence, and costs
    Zgraggen, Armin
    Stoffel, Sandro Tiziano
    Barbier, Michaela Carla
    Marbet, Urs Albert
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (05): : 761 - 778
  • [5] Efficacy of a Nationwide Screening Colonoscopy Program for Colorectal Cancer
    Pox, Christian P.
    Altenhofen, Lutz
    Brenner, Hermann
    Theilmeier, Arno
    Von Stillfried, Dominik
    Schmiegel, Wolff
    GASTROENTEROLOGY, 2012, 142 (07) : 1460 - +
  • [6] Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study)
    Sali, Lapo
    Grazzini, Grazia
    Carozzi, Francesca
    Castiglione, Guido
    Falchini, Massimo
    Mallardi, Beatrice
    Mantellini, Paola
    Ventura, Leonardo
    Regge, Daniele
    Zappa, Marco
    Mascalchi, Mario
    Milani, Stefano
    TRIALS, 2013, 14
  • [7] Informed decision-making in colorectal cancer screening using colonoscopy or CT-colonography
    de Haan, Margriet C.
    de Wijkerslooth, Thomas R.
    Stoop, Esther
    Bossuyt, Patrick
    Fockens, Paul
    Thomeer, Maarten
    Kuipers, Ernst J.
    Essink-Bot, Marie-Louise
    van Leerdam, Monique E.
    Dekker, Evelien
    Stoker, Jaap
    PATIENT EDUCATION AND COUNSELING, 2013, 91 (03) : 318 - 325
  • [8] Clinical stages of colorectal cancer diagnosed in obese and overweight individuals in the Polish Colonoscopy Screening Program
    Spychalski, Piotr
    Kobiela, Jarek
    Wieszczy, Paulina
    Kaminski, Michat F.
    Regula, Jaroslaw
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (06) : 790 - 797
  • [9] Colonoscopy screening for colorectal cancer in Egypt: a nationwide cross-sectional study
    Abdallah R. Allam
    Mostafa A. Elsayed
    Ibrahim Tawfiq Daghash
    Ali M. Abdelaziz
    Omnia M. Mostafa
    Hamdy Khaled Sabra
    Ahmed Monib Eldaboush
    Noor Maged Badrawy Ahmed
    Rawan Tarek Elweza
    Enas Sherif Adwy
    Abdelrahman Elbendary Hammad
    Ibrahim Ali Kabbash
    Ahmed Hafez Allam
    Ammar Ayman Bahbah
    Marwa Ibrahim Ewis
    Mohamed Mohamed Shawqi
    Mostafa B. Behery
    Yara Mohamed El-Said
    Ahmed Eid Radwan
    Mahmoud T. KhallafAllah
    Omar Ali Aboshady
    Mohamed A. Gouda
    BMC Cancer, 24
  • [10] Colonoscopy screening for colorectal cancer in Egypt: a nationwide cross-sectional study
    Allam, Abdallah R.
    Elsayed, Mostafa A.
    Daghash, Ibrahim Tawfiq
    Abdelaziz, Ali M.
    Mostafa, Omnia M.
    Sabra, Hamdy Khaled
    Eldaboush, Ahmed Monib
    Ahmed, Noor Maged Badrawy
    Elweza, Rawan Tarek
    Adwy, Enas Sherif
    Hammad, Abdelrahman Elbendary
    Kabbash, Ibrahim Ali
    Allam, Ahmed Hafez
    Bahbah, Ammar Ayman
    Ewis, Marwa Ibrahim
    Mohamed Shawqi, Mohamed
    Behery, Mostafa B.
    Mohamed El-Said, Yara
    Radwan, Ahmed Eid
    Khallafallah, Mahmoud T.
    Aboshady, Omar Ali
    Gouda, Mohamed A.
    BMC CANCER, 2024, 24 (01)